A previous research identified a reduction in the IL11 level in the context of cerebral ischemia–reperfusion injury [49], while administration of IL11 notably mitigated the activation of astrocytes and microglia induced by ischemia and also reduced the production of pro-inflammatory cytokines [49]. Here, IL11 is linked to ischemia.